Characteristics associated with use of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Burkina Faso, Democratic Republic of Congo, and Uganda.

Philip Anglewicz,Elizabeth Larson,Pierre Akilimali,Georges Guiella,Patrick Kayembe,Simon P S Kibira,Fredrick Makumbi,Scott Radloff

Contraception: X（2021）

引用 4|浏览2

暂无评分

摘要

It appears that DMPA-SC appeals to new contraceptive users in sub-Saharan Africa, which implies that DMPA-SC may have the potential to increase modern contraceptive prevalence in sub-Saharan African countries.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要